CG 7980
Alternative Names: CV 798Latest Information Update: 12 Oct 2006
At a glance
- Originator Cell Genesys
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 12 Oct 2006 Discontinued - Preclinical for Colorectal cancer in USA (unspecified route)
- 17 Sep 2001 Preclinical development for Colorectal cancer in USA (Unknown route)